Title : Inhibition of Glyoxalase-I Leads to Reduced Proliferation, Migration and Colony Formation, and Enhanced Susceptibility to Sorafenib in Hepatocellular Carcinoma.

Pub. Date : 2019

PMID : 31482070






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Inhibition of Glyoxalase-I Leads to Reduced Proliferation, Migration and Colony Formation, and Enhanced Susceptibility to Sorafenib in Hepatocellular Carcinoma. Sorafenib glyoxalase I Homo sapiens
2 The aim of this study was to analyze Glo-I in hepatocellular carcinoma (HCC) and the effect of the multi-tyrosine kinase inhibitor sorafenib on Glo-I. Sorafenib glyoxalase I Homo sapiens
3 Sorafenib treatment revealed elevation of Glo-I (10 muM: 209 +- 25%) and MGO. Sorafenib glyoxalase I Homo sapiens
4 In turn, sorafenib increases Glo-I. Sorafenib glyoxalase I Homo sapiens
5 Co-treatment using Glo-I inhibitors could enhance susceptibility of HCC to sorafenib. Sorafenib glyoxalase I Homo sapiens